NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...

Pioneering research led by the University of Bristol has repurposed a gene-editing tool to help shed light on the true ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Researchers developed a machine learning model, PAMmla, to predict properties of CRISPR-Cas9 enzymes, enhancing precision and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...

S cientists have knocked out genes that trigger cane toad tadpoles to turn into active toads, turning them into "Peter ...

In a shining moment for Uganda and the African scientific community, Dr Matthias Magoola, founder of Dei Biopharma, has been ...